In one study of CDI in HFD-induced obesity, inhibiting primary bile acid synthesis with the FXR antagonist obeticholic acid ameliorated CDI disease during later phases of infection but not in acute CDI19. This evidence concerns the gene NR1H4 and obesity due to melanocortin 4 receptor deficiency.